Moffitt Researcher Awarded Grant to Study New Treatments for Triple-Negative Breast Cancer

Get Permission

Error loading Partial View script (file: ~/Views/MacroPartials/TAP Article Portrait Widget.cshtml)

MOFFITT CANCER CENTER recently announced that Andriy Marusyk, PhD, was awarded a $450,000 research grant from Susan G. Komen. Dr. Marusyk is receiving 1 of 37 research grants looking into novel treatments for aggressive types of breast cancer. This year, Susan G. Komen is focusing on new treatments and understanding of the most lethal forms and stages of breast cancer. 

Dr. Marusyk is studying how cancer-associated fibroblasts decrease the effectiveness of therapies against triple-negative breast cancer and will investigate whether they are predictors of treatment response and potential ways to overcome drug resistance. His research is centered on the characterization of interactions between the malignant cells and tumor-associated fibroblasts, with the aim of developing the means to overcome stromal resistance to anticancer therapies. ■




By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.